Samyang Holdings Corporation

Samyang Holdings Corporation

KKRX:000070
52,600.00
KRW
-500.00
(-0.94%)
-42,348.58EPS
378.90BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
344,726.51
319,955.7
310,375.47
330,566.87
342,741.7
366,498.65
355,540.8
353,195.33
444,137.11
474,003.7
458,921.51
487,921.66
447,626.78
473,280.92
Basic EPS, GAAP
-4,832.27
363.97
6,649.9
3,233.68
5,388.73
10,004.17
4,410.77
14,622.92
33,975.23
10,147.98
24,635.94
4,039.06
-26,731
-27,487.55
Free Cash Flow per Basic Share
-14,187.78
8,998.93
-981.56
12,171.77
-15,628.43
-10,216.81
3,077.64
12,122.48
5,686.99
-7,478.35
21,851.96
17,778.22
17,169.75
18,128.05
Dividend per Share
2,180.17
1,899.62
2,294.55
2,289.62
2,996.66
3,011.52
3,635.43
3,614.01
4,187.73
4,813.56
5,400.47
5,430.92
5,051.1
- -
Book Value per Share
195,773.83
195,529.77
199,547.34
201,121.31
204,229.92
209,882.25
210,992.14
225,873.48
260,377.9
266,383.97
296,259.82
313,285.22
261,060.51
267,885.62
Tangible Book Value per Share
188,125.77
188,247.83
165,167.02
166,480.78
161,380.14
168,324.56
170,015.18
185,986.41
206,595.1
213,008.05
207,752.28
222,579.14
178,603.74
183,788.67
Basic Weighted Avg Shares
7
7
7
7
7
7
7
7
7
7
7
7
7
7
Sales/Revenue/Turnover
2,329,145
2,213,367
2,169,650
2,311,465
2,396,290
2,563,476
2,488,563
2,471,226
3,107,313
3,316,778
3,210,853
3,415,011
3,348,287
3,376,085
Operating Margin (%)
0.11
2.88
4.92
6.1
4.12
5.4
3.19
6.89
11.32
3.99
2.95
3.16
3.25
3.67
Depreciation Expense
57,940
54,194
70,006
82,680
76,558
77,027
91,727
93,176
92,264
114,032
113,398
135,863
139,656
27,074
Net Income, GAAP
-32,649
2,518
46,485
22,611
37,676
69,974
30,873
102,313
237,701
71,009
172,366
28,270
-199,950
-196,079
Effective Tax Rate (%)
- -
54.68
25.63
36.56
24.81
20.72
23.42
16.06
20.53
16.43
14.83
36.79
- -
- -
Profit Margin (%)
-1.4
0.11
2.14
0.98
1.57
2.73
1.24
4.14
7.65
2.14
5.37
0.83
-5.97
-5.81
Working Capital
376,638
444,813
455,392
413,015
588,280
400,738
732,347
793,869
648,264
992,923
530,264
877,273
322,784
150,450
LT Debt
163,903
306,271
545,091
443,999
638,114
502,211
884,300
899,711
778,369
1,029,881
780,492
1,035,549
844,694
515,721
Total Equity
1,658,209
1,654,390
1,796,363
1,850,632
1,939,788
2,001,942
2,029,507
2,155,787
2,425,407
2,523,511
2,796,536
2,998,088
2,652,535
2,719,644
Return on Invested Capital (%)
- -
1.27
3.18
3.38
2.73
3.94
2.07
4.45
7.86
2.87
1.92
1.51
- -
- -
Return on Capital (%)
- -
-0.4
1.26
-0.17
0.98
2.05
0.8
2.68
6.32
1.69
3.79
0.17
- -
- -
Return on Common Equity (%)
-2.6
0.19
3.5
1.68
2.77
5.03
2.18
6.97
14.55
4.01
9.12
1.38
-10.17
-9.61

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
578,862
797,389
1,386,594
LT Borrowings
821,399
530,850
493,006
LT Finance Leases
23,295
23,323
22,715
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
7
Market Capitalization
402,664
461,386
378,896

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,760,159
1,695,395
2,386,831
Cash, Cash Equivalents & STI
876,812
708,278
1,345,108
Accounts Receivable, Net
327,397
407,465
438,797
Inventories
500,239
502,717
537,024
Total Current Liabilities
1,437,376
1,662,872
2,236,380
Payables & Accruals
- -
- -
- -
ST Debt
578,862
797,389
1,386,594
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.17%
4.61%
-11.53%
Free Cash Flow
-213.2%
-138.44%
3.21%
Net Income, GAAP
-40.94%
-137.19%
-807.29%
Sales/Revenue/Turnover
4.73%
6.74%
-1.95%
Total Cash Common Dividend
9.44%
8.6%
-0.6%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
871,146
917,357
889,190
875,571
3,415,011
2025
833,392
870,297
889,632
685,205
3,348,287
2026
838,281
962,967
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,603
2,307
991
-3,595.09
4,039.06
2025
3,553.4
3,527.95
2,457.07
-35,358.72
-26,731
2026
2,997.18
4,645
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5,430.92
2025
- -
- -
- -
- -
5,051.1
2026
- -
- -
- -
- -
- -

Company Description

CEO
Tae-Ung Eom
Full Time Employees
145
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
31 Jongno 33-gil Seoul SL South Korea 03129
IPO Date
Dec 27, 1968
Business
Samyang Holdings Corporation serves as the holding company for the Samyang Group, overseeing diversified operations in chemicals, food, biopharmaceuticals, packaging, and other sectors primarily in South Korea, China, Japan, other Asian countries, Europe, and internationally. Founded in 1924 and headquartered in Seoul, South Korea, the company operates through three main segments: Chemicals, Food, and Others; its core chemical offerings include engineering plastics, ion exchange resins, bisphenol A (BPA) chemicals, personal care materials, eco-friendly materials, semiconductor materials, polycarbonate resin, polybutylene terephthalate, high-purity terephthalic acid, and related products; food products encompass sugar, starch sugar, flour, sweeteners, wheat, processed foods, processed oils and fats, water-soluble dietary fibers, and health and wellness items alongside ServeQ-branded food service distribution; biopharmaceuticals feature medical devices, anticancer drugs, drug delivery systems for gene therapeutics, and oncology products exported to over 25 countries; packaging involves PET bottles, recycled PET chips, and aseptic filling; additional offerings comprise cosmetics under ABOUT ME and MediAnswer brands, raw materials for household goods, IT services including ERP, CRM, and BI solutions for public, finance, and manufacturing sectors, plus research, trading, and leasing activities. In recent developments, Samyang Holdings acquired U.S.-based Verdant Specialty Solutions for $250 million from OpenGate Capital in early 2024 to bolster its personal care and specialty chemicals portfolio under the Vision 2025 growth strategy targeting KRW6 trillion in annual revenue, enhancing synergies with subsidiary KCI in cationic surfactants and expanding global market share in biodegradable and functional ingredients; the company also pursues further diversification, including potential acquisitions in Japan's semiconductor supply chain as announced in mid-2025, while advancing high-value materials in health, wellness, semiconductors, and eco-friendly sectors.